These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8879461)
21. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia. Morris R; Robinson G; Tilyard M; Gurr E N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723 [TBL] [Abstract][Full Text] [Related]
22. Choice of cholesterol-lowering drugs. Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674 [No Abstract] [Full Text] [Related]
23. Screening for high blood cholesterol. U.S. Preventive Services Task Force. Am Fam Physician; 1990 Feb; 41(2):503-13. PubMed ID: 2405605 [TBL] [Abstract][Full Text] [Related]
24. Revisiting the effectiveness of the National Cholesterol Education Program's Step I and Step II diets: cholesterol-lowering diets in a pharmaceutically driven world. Denke MA Am J Clin Nutr; 1999 Apr; 69(4):581-2. PubMed ID: 10197556 [No Abstract] [Full Text] [Related]
25. Hypercholesterolemia screening. Does knowledge of blood cholesterol level affect dietary fat intake? Aubin M; Godin G; Vézina L; Maziade J; Desharnais R Can Fam Physician; 1998 Jun; 44():1289-97. PubMed ID: 9640523 [TBL] [Abstract][Full Text] [Related]
28. The impact of lipid lowering in coronary artery disease. Goldberg AC Curr Opin Cardiol; 1997 Sep; 12(5):488-93. PubMed ID: 9352177 [TBL] [Abstract][Full Text] [Related]
29. Improving medication adherence in hypercholesterolemia: challenges and solutions. Gatwood J; Bailey JE Vasc Health Risk Manag; 2014; 10():615-25. PubMed ID: 25395859 [TBL] [Abstract][Full Text] [Related]
30. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"? Masana L; Pedro-Botet J; Civeira F Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557 [No Abstract] [Full Text] [Related]
31. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related]
32. When a statin fails. Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290 [No Abstract] [Full Text] [Related]
33. Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied. Masterjohn C Am Heart J; 2009 Jul; 158(1):e11; author reply e13. PubMed ID: 19540377 [No Abstract] [Full Text] [Related]
34. LDL-Cholesterol is the King. Goumas GS Angiology; 2009; 60(3):387-8. PubMed ID: 19497926 [No Abstract] [Full Text] [Related]
35. [On the current debate on lowering LDL cholesterol with ezetimibe]. Breuer HW Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008 [No Abstract] [Full Text] [Related]
36. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk. Agabiti Rosei E; Salvetti M High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia. Denke MA; Grundy SM Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022 [TBL] [Abstract][Full Text] [Related]
38. Addressing the spectrum of hypercholesterolemia. Grundy SM; Mazzaferri EL Hosp Pract (1995); 1996 Jun; 31(6):43-8, 53-5, 59; discussion 60. PubMed ID: 8675545 [TBL] [Abstract][Full Text] [Related]
39. The effects of dietary cholesterol-lowering on psychological symptoms: a randomised controlled study. Weidner G; Connor SL; Gerhard GT; Duell PB; Connor WE Psychol Health Med; 2009 May; 14(3):255-61. PubMed ID: 19444703 [TBL] [Abstract][Full Text] [Related]